Heilongjiang's latest epidemic notice
Author:Heilongjiang Government Affair Time:2022.06.20
At 0-24:00 on June 19, 2022, there was no new local new crown pneumonia epidemic information report in Heilongjiang Province, and one of the asymptomatic infected infected from overseas (Harbin Report, South Korea input). On that day, 1 case of input cases were entered overseas, and one of the asymptomatic infected infected from medical observation was lifted.
As of 24:00 on June 19, there were 2 confirmed cases in the province and 4 asymptoms of infection abroad.
At present, the overall situation of the epidemic situation in my country has remained stable, but the risk of spreading in individual localities still exists, and it cannot be relaxed. The general public should continue to tighten the epidemic to prevent and control the string, firmly establish the concept of "everyone is the first person in charge of his own health", standardize vaccination, and adhere to "wearing masks, shampooing hands, ventilation, and not gathering." Pay close attention to the dynamics of the epidemic, such as intersection with the activity trajectory with the positive infected person, or if there is a history of domestic and high -risk areas and the history of domestic high -risk areas and the area of immune -related areas, immediately actively report to the communities (villages) and work units where they are located. Control measures. If you have symptoms such as fever, dry cough, fatigue, sore throat, smell (taste), diarrhea, etc., please do not take the medicine by yourself. You need to wear a mask to go to the nearest medical institution to send a hot kidney consultation and consultation. And actively inform the history of living and contact.
The cities and prefectures epidemic prevention and control headquarters should investigate the history of residence (return) in the recently -related areas of immune -related areas, strengthen "big data+grid", accurately grasp and control relevant risks personnel, and the risk personnel who detects the infection After the risk, we must implement classification and control measures such as code, nucleic acid detection, isolation management, and health monitoring.
- END -
Another License Out!East China Pharmaceutical Liculucan peptide is as soon as possible
On June 23, East China Pharmaceutical (SZ.000963) announced that it would reach a ...
The National Health and Health Commission: The national epidemic situation has maintained smoothly, but the local area still fluctuates
Press conference on the joint control mechanism of the State Council. Xinhua News ...